Within the tumor microenvironment (TME), where myeloid and T cells demonstrate preferential glucose uptake over malignant cells (14), the secreted protein FGA orchestrates tumor matrix remodeling and immune response modulation through xCT expression regulation, thereby shaping clinical prognosis. The gene discussed is SLC7A11; the disease is neoplasm.